BACKGROUND: Albuminuria and estimated glomerular filtration rate (eGFR) are each associated with increased risk of cognitive impairment, but their joint association is unknown. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: A US national sample of 19,399 adults without cognitive impairment at baseline participating in the REGARDS (Reasons for Geographic and Racial Disparities in Stroke) Study. PREDICTORS: Albuminuria was assessed using urine albumin-creatinine ratio (UACR) and GFR was estimated using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation. OUTCOMES: Incident cognitive impairment was defined as score ≤4 on the 6-Item Screener at the last follow-up visit. RESULTS: During a mean follow-up of 3.8 ± 1.5 years, UACRs of 30-299 and ≥300 mg/g were associated independently with 31% and 57% higher risk of cognitive impairment, respectively, relative to individuals with UACR <10 mg/g. This finding was strongest for those with high eGFRs and attenuated at lower levels (P = 0.04 for trend). Relative to eGFR ≥60 mL/min/1.73 m(2), eGFR <60 mL/min/1.73 m(2) was not associated independently with cognitive impairment. However, after stratifying by UACR, eGFR <60 mL/min/1.73 m(2) was associated with a 30% higher risk of cognitive impairment in participants with UACR <10 mg/g, but not higher UACRs (P = 0.04 for trend). LIMITATIONS: Single measures of albuminuria and eGFR, screening test of cognition. CONCLUSIONS: When eGFR was preserved, albuminuria was associated independently with incident cognitive impairment. When albuminuria was <10 mg/g, low eGFR was associated independently with cognitive impairment. Albuminuria and low eGFR are complementary, but not additive, risk factors for incident cognitive impairment. Published by Elsevier Inc.
BACKGROUND:Albuminuria and estimated glomerular filtration rate (eGFR) are each associated with increased risk of cognitive impairment, but their joint association is unknown. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: A US national sample of 19,399 adults without cognitive impairment at baseline participating in the REGARDS (Reasons for Geographic and Racial Disparities in Stroke) Study. PREDICTORS: Albuminuria was assessed using urine albumin-creatinine ratio (UACR) and GFR was estimated using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation. OUTCOMES: Incident cognitive impairment was defined as score ≤4 on the 6-Item Screener at the last follow-up visit. RESULTS: During a mean follow-up of 3.8 ± 1.5 years, UACRs of 30-299 and ≥300 mg/g were associated independently with 31% and 57% higher risk of cognitive impairment, respectively, relative to individuals with UACR <10 mg/g. This finding was strongest for those with high eGFRs and attenuated at lower levels (P = 0.04 for trend). Relative to eGFR ≥60 mL/min/1.73 m(2), eGFR <60 mL/min/1.73 m(2) was not associated independently with cognitive impairment. However, after stratifying by UACR, eGFR <60 mL/min/1.73 m(2) was associated with a 30% higher risk of cognitive impairment in participants with UACR <10 mg/g, but not higher UACRs (P = 0.04 for trend). LIMITATIONS: Single measures of albuminuria and eGFR, screening test of cognition. CONCLUSIONS: When eGFR was preserved, albuminuria was associated independently with incident cognitive impairment. When albuminuria was <10 mg/g, low eGFR was associated independently with cognitive impairment. Albuminuria and low eGFR are complementary, but not additive, risk factors for incident cognitive impairment. Published by Elsevier Inc.
Authors: Coen D A Stehouwer; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter Journal: Kidney Int Suppl Date: 2004-11 Impact factor: 10.545
Authors: Sara-Joan Pinto-Sietsma; Wilbert M T Janssen; Hans L Hillege; Gerjan Navis; Dick DE Zeeuw; Paul E DE Jong Journal: J Am Soc Nephrol Date: 2000-10 Impact factor: 10.121
Authors: Oscar L Lopez; William J Jagust; Corinne Dulberg; James T Becker; Steven T DeKosky; Annette Fitzpatrick; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: Stephen L Seliger; David S Siscovick; Catherine O Stehman-Breen; Daniel L Gillen; Annette Fitzpatrick; Anthony Bleyer; Lew H Kuller Journal: J Am Soc Nephrol Date: 2004-07 Impact factor: 10.121
Authors: Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie Journal: Med Care Date: 2002-09 Impact factor: 2.983
Authors: Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman Journal: Nephrol Dial Transplant Date: 2015-02-26 Impact factor: 5.992
Authors: Virginia G Wadley; Leslie A McClure; David G Warnock; Caroline L Lassen-Greene; Robert J Hopkin; Dawn A Laney; Virginia M Clarke; Manjula Kurella Tamura; George Howard; Katherine Sims Journal: JIMD Rep Date: 2015-01-08
Authors: Ann M O'Hare; Rod Walker; Sebastian Haneuse; Paul K Crane; Wayne C McCormick; James D Bowen; Eric B Larson Journal: J Am Geriatr Soc Date: 2012-12 Impact factor: 5.562
Authors: Johannes B Scheppach; Josef Coresh; Aozhou Wu; Rebecca F Gottesman; Thomas H Mosley; David S Knopman; Morgan E Grams; A Richey Sharrett; Silvia Koton Journal: Am J Kidney Dis Date: 2020-05-16 Impact factor: 8.860
Authors: Meera N Harhay; Dawei Xie; Xiaoming Zhang; Chi-Yuan Hsu; Eric Vittinghoff; Alan S Go; Stephen M Sozio; Jacob Blumenthal; Stephen Seliger; Jing Chen; Rajat Deo; Mirela Dobre; Sanjeev Akkina; Peter P Reese; James P Lash; Kristine Yaffe; Manjula Kurella Tamura Journal: Am J Kidney Dis Date: 2018-05-02 Impact factor: 8.860